CLINICAL_TRIALS
trial_result
· 2015-02-12
Clinical Trial Update: NVA237 Versus Placebo 12-week Efficacy Study [Phase 3]
Summary
A Phase 3 trial comparing NVA237 to placebo in chronic obstructive pulmonary disease has completed enrollment and posted results on February 12, 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-02-12